{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:40:44Z","timestamp":1761100844897,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5821,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.exphem.2006.03.008","type":"journal-article","created":{"date-parts":[[2006,6,22]],"date-time":"2006-06-22T07:44:37Z","timestamp":1150962277000},"page":"895-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Graft engineering using ex vivo methods to limit GVHD: Fludarabine treatment generates superior GVL effects in allogeneic BMT"],"prefix":"10.1016","volume":"34","author":[{"given":"Jian-Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia R.","family":"Giver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2006.03.008_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/bbmt.2002.v8.abbmt080625","article-title":"Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion","volume":"8","author":"Soiffer","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.03.008_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/10428190009087014","article-title":"Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma","volume":"38","author":"Fowler","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2006.03.008_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1067\/mlc.2003.5","article-title":"Recent advances in allogeneic hematopoietic stem-cell transplantation","volume":"141","author":"Devine","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.exphem.2006.03.008_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1703803","article-title":"Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft","volume":"31","author":"Lee","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.03.008_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bmt.1704027","article-title":"Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality","volume":"31","author":"Robin","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.03.008_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI200316950","article-title":"Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720","volume":"111","author":"Kim","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2006.03.008_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood.V94.2.825","article-title":"Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease","volume":"94","author":"Krijanovski","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.bmt.1703895","article-title":"\u201cGVHD\u201d: graft-versus-host disease or graft-versus-Hodgkin's disease? an old acronym with new meaning","volume":"31","author":"Porter","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.03.008_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI7111","article-title":"IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation","volume":"104","author":"Teshima","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2006.03.008_bib10","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1182\/blood.V99.11.4207","article-title":"Donor-derived interferon \u03b3 separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells","volume":"99","author":"Yang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib11","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood.V94.9.3222","article-title":"Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease","volume":"94","author":"Waller","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib12","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.4049\/jimmunol.163.9.5145","article-title":"Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation","volume":"163","author":"Truitt","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.03.008_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1083-8791(03)00229-5","article-title":"Ex-vivo fludarabine exposure inhibits GvHD activity of allogeneic T-cells while preserving GvL effects","volume":"9","author":"Giver","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.03.008_bib14","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.4049\/jimmunol.171.11.6023","article-title":"Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation","volume":"171","author":"Roback","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.03.008_bib15","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(96)91681-5","article-title":"Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL","volume":"347","author":"Johnson","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2006.03.008_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V74.1.19.19","article-title":"Fludarabine: a new agent with major activity against chronic lymphocytic leukemia","volume":"74","author":"Keating","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0008-8749(90)90208-9","article-title":"Purine nucleoside modulation of functions of human lymphocytes","volume":"129","author":"Priebe","year":"1990","journal-title":"Cell Immunol"},{"key":"10.1016\/j.exphem.2006.03.008_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4615-4987-1_12","article-title":"Clinical use of irradiated donor lymphocytes in bone marrow transplantation","volume":"101","author":"Ship","year":"1999","journal-title":"Cancer Treat Res"},{"issue":"Suppl 2","key":"10.1016\/j.exphem.2006.03.008_bib19","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/sj.bmt.1702347","article-title":"New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells","volume":"25","author":"Waller","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.03.008_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1537-2995.1997.37497265344.x","article-title":"Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light","volume":"37","author":"Lin","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.exphem.2006.03.008_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jlb.54.2.138","article-title":"Selective inactivation of lymphocytes after psoralen\/ultraviolet light (PUVA) treatment without affecting systemic immune responses","volume":"54","author":"Laskin","year":"1993","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2006.03.008_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1751-1097.1996.tb05657.x","article-title":"PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T-lymphocytes","volume":"63","author":"Johnson","year":"1996","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.exphem.2006.03.008_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-3-642-78771-3_31","article-title":"Systemic treatment for cutaneous lymphomas","volume":"139","author":"Mielke","year":"1995","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.exphem.2006.03.008_bib24","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood.V92.9.3098","article-title":"Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease","volume":"92","author":"Greinix","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1365-2141.1997.1092927.x","article-title":"Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease","volume":"97","author":"Dall'Amico","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.03.008_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0022-202X(89)90180-2","article-title":"Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes","volume":"92","author":"Perez","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.exphem.2006.03.008_bib27","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1182\/blood.V93.9.3140","article-title":"Prevention of transfusion-associated graft-versus-host disease by photochemical treatment","volume":"93","author":"Grass","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib28","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1182\/blood.V89.9.3477","article-title":"The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia properties","volume":"89","author":"Boyer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib29","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-065X.1997.tb00976.x","article-title":"Recent advances in graft-versus-host disease (GVHD) prevention","volume":"157","author":"Blazar","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.exphem.2006.03.008_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2006.03.008_bib32","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood.V83.12.3758.3758","article-title":"Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin\u2212Sca-1+ hematopoietic stem cells","volume":"83","author":"Uchida","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbmt.2004.05.007","article-title":"Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation","volume":"10","author":"Li","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.03.008_bib34","first-page":"3355","article-title":"Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes","volume":"61","author":"Kornblau","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2006.03.008_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbmt.2004.12.332","article-title":"Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation","volume":"11","author":"Hossain","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2006.03.008_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1385\/IR:29:1-3:269","article-title":"Reconstructing immunity after allogeneic transplantation","volume":"29","author":"Giver","year":"2004","journal-title":"Immunol Res"},{"key":"10.1016\/j.exphem.2006.03.008_bib37","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","article-title":"Transfer of allogeneic CD62L memory T cells without graft-versus-host disease","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI19095","article-title":"Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease","volume":"112","author":"Sondel","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2006.03.008_bib39","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood-2003-12-4431","article-title":"Human CD62L\u2212 memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion","volume":"104","author":"Foster","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.03.008_bib40","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.4049\/jimmunol.166.9.5835","article-title":"Anti-CD3 \u025b F(ab\u2032)2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens","volume":"166","author":"Yu","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.03.008_bib41","first-page":"221","article-title":"Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation","volume":"5","author":"Zeder","year":"1998","journal-title":"Cancer Res Ther Control"},{"key":"10.1016\/j.exphem.2006.03.008_bib42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1083-8791(03)00127-7","article-title":"Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation","volume":"9","author":"Waller","year":"2003","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06001950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06001950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:22:16Z","timestamp":1759566136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X06001950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0301472X06001950"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2006.03.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Graft engineering using ex vivo methods to limit GVHD: Fludarabine treatment generates superior GVL effects in allogeneic BMT","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2006.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}